Products for administering an initial high dose of Cetrorelix and producing a combination package for use when treating diseases

US5663145A · kind A · utility

Assignee

• Asta Medica Aktiengesellschaft · DE

Inventors

• Jurgen Engel · Alzenau, DE
• Peter Hilgard · Frankfurt, DE
• Thomas Reissmann · Frankfurt, DE

Key dates

• Filing date: Dec 8, 1994
• Grant date: Sep 2, 1997
• Expiry date: Dec 8, 2014

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/09
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

For application during the treatment of benign and malign tumour diseases, the product according to the invention containing the initial dose of Cetrorelix acetate and one or more maintenance doses of Cetrorelix acetate, Cetrorelix embonate or a slow-release form of Cetrorelix, is used as a combination preparation for treatment to be administered at specific time intervals.